|
ESTRO - NUCLETRON BRACHYTHERAPY AWARD |
 |
OC-135 Does oncoplastic breast conserving surgery contraindicate partial breast multicatheter brachytherapy (APBI)?
A. Roth1, D. Kauer-Dorner2, A. Resch2, P. Niehoff3, C. Melchert1, D. Berger2, G. Kovács1
1University of Luebeck, Interdisciplinary Brachytherapy, Luebeck, Germany
2AKH-Vienna, Radiotherapy, Vienna, Austria
3Kliniken der Stadt Köln, Radiotherapy, Cologne, Germany
|
gEC-ESTRO BEST JUNIOR pRESENTATION sponsored by Nucletron
|
|
OC-069 Bringing in-vivo fiber-coupled brachytherapy dosimetry to the patient
G. Kertzscher1, C.E. Andersen1, J.C. Lindegaard2, L.U. Fokdal2, M. Paludan2, S.K. Nielsen3, K. Tanderup4
1Technical University of Denmark, Center for Nuclear Technologies, Roskilde, Denmark
2Aarhus University Hospital, Department of Oncology, Aarhus, Denmark
3Aarhus University Hospital, Department of Medical Physics, Aarhus, Denmark
4Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark
BEST pOSTER AWARD
PO-205 Potential benefit of adaptive treatment planning for PDR prostate brachytherapy
A.M. Dinkla1, B.R. Pieters1, P. Meijnen1, C. Koedooder1, N. van Wieringen1, R. van der Laarse1, J.N. van der Grient1, A. Bel1
1Amsterdam Medical Center, Radiation Oncology, Amsterdam, The Netherlands
|
TRAVEL gRANTS |
|
Ahmed Salem, Jordan
Jeffrey Tuan, Italy
Ezgi Oymak, Turkey
Carminia Lapuz, Australia
Manoj Kumar Behera, India
Ana Vasconcelos, Portugal
Emmanuel Oyekunle, Nigeria
Ana Kiess, USA
Esma Efe, Turkey